title: Medication safety is still an issue in obstetrics 50 years after the Kefauver-Harris amendments: the case of progestogens.
authors.affiliation: Maternal Fetal Medicine, University of Kentucky, Lexington, KY, USA. john.obrien2@uky.edu
authors.forename: J M
authors.initials: JM
authors.lastname: O'Brien
mesh_terms: D000077713:17 alpha-Hydroxyprogesterone Caproate; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000009:adverse effects; D007880:Legislation, Drug; D009774:Obstetrics / Q000379:methods*; D061214:Patient Safety; D011247:Pregnancy; D047928:Premature Birth / Q000188:drug therapy* / Q000517:prevention & control; D045167:Progesterone Congeners / Q000009:adverse effects*; D011372:Progestins / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D006908:Hydroxyprogesterones; D045167:Progesterone Congeners; D011372:Progestins; D000077713:17 alpha-Hydroxyprogesterone Caproate